Previous Article | Next Article 
Infection and Immunity, September 1999, p. 4594-4602, Vol. 67, No. 9
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Murine Splenocytes Induce Severe Gastritis and
Delayed-Type Hypersensitivity and Suppress Bacterial Colonization in
Helicobacter pylori-Infected SCID Mice
Kathryn A.
Eaton,*
Susan R.
Ringler, and
Stephen
J.
Danon
Department of Veterinary Biosciences, Ohio
State University, Columbus, Ohio 43210
Received 7 December 1998/Returned for modification 3 February
1999/Accepted 1 June 1999
 |
ABSTRACT |
The goal of this study was to evaluate the role of host immunity in
gastritis and epithelial damage due to Helicobacter pylori. Splenocytes from H. pylori-infected and uninfected C57BL/6
mice were adoptively transferred to H. pylori-infected and
uninfected severe combined immunodeficient (SCID) mice. Transfer was
verified by flow cytometry, and all mice were evaluated for the
presence of delayed-type hypersensitivity (DTH) by footpad inoculation with sterile H. pylori sonicate and for humoral immunity by
enzyme-linked immunosorbent assay. The severity of gastritis and
gastric epithelial damage was quantified histologically, epithelial
proliferation was determined by proliferating cell nuclear antigen
staining, and colonization was quantified by culture. C57BL/6 mice, but not nonrecipient SCID mice, developed moderate gastritis in response to
H. pylori. In contrast, recipient SCID mice developed
severe gastritis involving 50 to 100% of the gastric mucosa and strong DTH responses not present in C57BL/6 mice. DTH, but not serum anti-H. pylori immunoglobulin G, correlated with adoptive
transfer, gastritis, and bacterial clearance. Severe gastritis, but not bacterial colonization, was associated with epithelial metaplasia, erosions, and an elevated labeling index. This study demonstrates that
(i) adaptive immunity is essential for development of gastritis due to
H. pylori in mice, (ii) T-cell-enriched lymphocytes in SCID
mice induce DTH and gastritis, which is more severe than donor
gastritis, and (iii) the host inflammatory response, not direct
bacterial contact, causes epithelial damage. The greater severity of
gastritis in recipient SCID mice than in donor C57BL/6 mice suggests
that gastritis is due to specific T-cell subsets and/or the absence of
regulatory cell subsets in the transferred splenocytes.
 |
INTRODUCTION |
In recent years, studies of the host
response to Helicobacter pylori infection have been
primarily directed at a protective effect. Most studies have been
directed towards the development of vaccination strategies (3,
14-17, 28, 35); only a few studies have examined the role of the
host in tissue damage associated with infection by H. pylori
(30, 31). In spite of this emphasis on vaccination schemes,
a body of evidence regarding the pathogenesis of gastritis is
accumulating. Marked differences in the severity of disease in
different host species and, more recently, in different strains of the
same host species have led to the suggestion that host immune response
is important in determining the severity of gastritis. In some hosts,
such as humans (26), rodents (12, 19, 27), and
cheetahs (13), infection with some Helicobacter species results in severe gastritis with attendant epithelial changes
ranging from erosion to ulceration and from metaplasia to neoplasia. In
other hosts, such as dogs and cats (9, 21, 33, 34, 41),
gastric Helicobacter infection results in little or no
inflammation and no epithelial changes. In addition to species differences, host strain differences determine the outcome of infection. C57BL/6 mice are readily susceptible to some species and
strains of Helicobacter and develop gastritis in response to
infection, whereas BALB/c mice are more resistant to both
colonization and inflammation (32, 38). These differences
suggest that host response is important in determining if an infected
individual develops severe gastritis, ulcers, neoplasia, only
mild chronic gastritis, or no disease.
In addition to host response, a large body of data has been generated
regarding the potential role of bacterial factors in the damage of host
gastric mucosa. A number of bacterial virulence factors, including
vacA (1), cagA and the related
cag pathogenicity island (37), and
iceA1 (36), have been shown to be associated with
the increased severity of disease in humans, and there is clear
evidence that in vitro H. pylori gene products can cause epithelial damage (6) or induce cytokine secretion
potentially leading to inflammation (7). In spite of these
correlations, however, studies evaluating the roles of bacterial
factors in vivo in experimental models have been limited, and a direct
effect of bacterial products causing host epithelial cell damage in
vivo is controversial (8, 40). Thus, it is not clear if
bacterial products damage host cells directly in vivo, if damage occurs as a by-product of host inflammation, or if both effects are important.
The overall goals of this study were (i) to demonstrate that H. pylori-associated gastritis and gastric epithelial damage are
dependent on an intact adaptive immune response, (ii) to determine if
such gastritis can be transferred to immunodeficient hosts by
splenocytes from infected or uninfected donor mice, and (iii) to
determine if gastritis is accompanied by in vivo evidence of a
T-cell-mediated immune response (delayed-type hypersensitivity [DTH] response).
 |
MATERIALS AND METHODS |
Mice.
Four- to six-week-old female helicobacter-free
C57BL/6J mice and C57BL/6J scid/scid (severe combined
immunodeficient [SCID]) mice were purchased from Jackson Laboratory
(Bar Harbor, Maine). SCID mice are deficient in a DNA-dependent kinase
necessary for recombination of both T-cell receptors and antibodies
(22). Thus, neither T nor B cells mature in these mice, and
they have no adaptive immunity. Mice were housed in microisolator cages and offered sterile Teklad lab chow and water ad libitum. One week
following arrival, SCID mice were anesthetized with methoxyflurane, and
100 µl of blood was collected from the periorbital sinus. Serum was
separated and stored at
20°C until used for the determination of
the immunoglobulin G (IgG) level by enzyme-linked immunosorbent assay
(ELISA) (see below). SCID phenotype was verified by the absence of
detectable mouse IgG (optical density at 405 nm, <0.1) and/or the
absence of a detectable serologic response to antigenic challenge.
For bacterial inoculation, animals were given 0.2 ml of a suspension of
broth-cultured H. pylori SS1 containing 109 CFU
of bacteria in logarithmic phase per ml. Mice were inoculated three
times at 2-day intervals by oral gavage. At the termination of the
inoculation phase of the study, mice were anesthetized by injection of
phenobarbital and exsanguinated by cardiac puncture. The stomach and
spleen were aseptically removed, the stomach was bisected along the
greater and lesser curvatures, the squamous portion was removed, and
half the stomach was homogenized for the determination of bacterial
colonization by plate dilution as previously described (11).
The remainder of the stomach was sectioned transversely into 1-mm
strips; one strip was frozen in Tissue-Tek OCT compound (Sakura, Inc.,
Torrance, Calif.) and stored at
70°C, and the remainder was fixed
by immersion in 10% neutral buffered formalin, embedded in paraffin,
cut into 6-µm sections, and stained with hematoxylin and eosin and
Genta (20) stains. Some of the spleens were placed in cold
(4°C) Hanks balanced salt solution for the isolation of splenocytes
(see below). All procedures involving animals were approved by the Ohio
State University laboratory animal care and use committee.
DTH response.
For the preparation of bacterial sonicate,
broth cultures containing approximately 109 CFU of H. pylori per ml were washed twice in phosphate-buffered saline
(PBS), resuspended in 1/10 of the original volume of PBS, and sonicated
with a Bradford sonifier at 4°C for two cycles of four 30-s bursts
with 30-s rests. Intact bacteria were removed by centrifugation (5,000 rpm in a Sorvall RC-5B refrigerated superspeed centrifuge for 10 min),
and sterility was ascertained by culture. The protein concentration was
determined by a microprotein assay (Bio-Rad Laboratories, Hercules,
Calif.), and aliquots were stored at
20°C until used. For mouse
footpad injection, sonicates were adjusted to 10 µg/30 µl, and each
mouse was given 30 µl of sonicate by injection into one hind footpad.
Previous evaluation determined that 10 µg of antigen elicited a
detectable and specific response (present only in sensitized mice
[data not shown]). The opposite footpad received sterile PBS. Footpad
thickness was measured with a dial thickness gauge (Swiss Precision
Instruments, Los Angeles, Calif.) before injection, 24 h after
injection, and, in some cases, 48 h after injection.
Bacterial strains.
H. pylori SS1 (25) was
kindly supplied by Adrian Lee. This strain is a cagA- and
VacA-positive human isolate which is adapted for the colonization of
mice. Bacteria were grown in brucella broth with 10% fetal calf serum
or on blood agar plates under microaerobic conditions at 37°C. Broth
cultures were enumerated by a hemacytometer and/or plate dilution.
Adoptive transfer.
For the isolation of splenocytes, spleens
were disaggregated in cold Hanks balanced salt solution, clumps were
allowed to settle out, and the supernatant was sedimented at 1,000 rpm
in an IEC PR-600 centrifuge for 10 min. Erythrocytes were removed by
hypotonic lysis, and the splenocytes were resuspended in Dulbecco's PBS (D-PBS). Splenocytes were examined for viability by trypan blue
exclusion and adjusted to 107 viable cells/ml, and
recipient SCID mice were given 0.1 ml by intraperitoneal injection 4 weeks after bacterial inoculation.
Flow cytometry.
Splenocytes from C57BL/6 and SCID mice were
isolated as described above, and 1 × 106 to 2 × 106 cells were resuspended in 100 µl of Fc Block
(Pharmingen, San Diego, Calif.) and incubated for 10 min at 4°C.
Fluorescein isothiocyanate- or phycoerythrin-labeled anti-CD4,
anti-CD8, or anti-CD45R/B220 (Pharmingen) was added, and cells were
incubated for 45 min at 4°C. Cells were washed three times in D-PBS
with bovine serum albumin and 0.1% NaN3 and resuspended in
100 µl of D-PBS, and 100 µl of 4% paraformaldehyde was added. Cell
suspensions were evaluated on an EPICS flow cytometer.
ELISA.
Murine IgG levels in SCID mice and anti-H.
pylori IgG levels in all mouse sera taken at termination (herein
referred to as terminal sera) were determined by ELISA. ELISA plates
(96 wells; Corning) were coated either with 4 µg of unconjugated goat
anti-mouse IgG (Pierce) per ml for the determination of circulating IgG
in naive SCID mice or with 100 µg of H. pylori SS1
sonicate per ml for the determination of the serologic response to
H. pylori. For the determination of mouse IgG levels, plates
were coated with IgG for 12 h at 4°C, washed, blocked with 200 µl of 0.1% bovine serum albumin per well, washed, and incubated for
2 h at room temperature with SCID mouse sera diluted 1:20. Plates
were washed, incubated with peroxidase-conjugated goat anti-mouse IgG for 90 min at room temperature, and washed again, and peroxidase was
detected by incubation with azino-bisthiosulfonate in the dark for 5 to
10 min. The optical density at 405 nm was recorded.
For the determination of anti-H. pylori IgM and IgG levels
in terminal sera (29), plates were coated with 100 µg of
H. pylori SS1 sonicate per ml for 48 h at 4°C,
washed, blocked with blocking buffer (gelatin [1 g/liter] in 0.1 M
PBS-0.02% sodium azide), washed again, and incubated for 90 min at
37°C with terminal mouse sera diluted 1:50. Plates were then washed
again, incubated with alkaline phosphatase-conjugated goat anti-mouse
IgM or IgG (Bio-Rad), and washed, and alkaline phosphatase was detected
with an alkaline phosphatase substrate kit (Bio-Rad) according to the
manufacturer's instructions.
Immunohistochemistry for expression of PCNA.
To determine
the labeling index, formalin-fixed sections were deparaffinized,
antigens were exposed with antigen retrieval solution (Bio Genex), and
the presence of proliferating cell nuclear antigen (PCNA) was
determined by histochemical staining. Primary antibody was from
Pharmingen (PC-10, mouse anti-PCNA), and secondary antibody was from
Vector Laboratories (biotinylated goat anti-mouse antibody). Antibody
staining was detected with an ABC detection kit from Vector
Laboratories, and slides were counterstained with hematoxylin. The
labeled and nonlabeled nuclei in three well-oriented glands in three
different locations in the gastric fundus were enumerated, and the
labeling index was calculated by dividing the number of labeled nuclei
by the total number of nuclei counted and then multiplying by 100.
Histologic evaluation.
The severity of gastritis in
hematoxylin-and-eosin-stained sections was determined by enumerating
the number of 20× microscopic fields containing the following
pathologic changes: (i) neutrophilic inflammation (polymorphonuclear
leukocytes [PMNs]), (ii) inflammatory infiltrate (lymphocytic,
plasmacytic, histiocytic, neutrophilic, or, most commonly, mixed) which
was severe enough to displace glands (gastritis), (iii) the destruction
of gastric glands or neutrophilic gland abscesses by inflammatory
infiltrate (adenitis), and (iv) the loss of normal fundic gland
morphology with a replacement of specialized cells by mucus-type
epithelium (metaplasia) and epithelial erosions. Genta-stained sections
were evaluated to determine the number of fields containing Alcian
blue-positive (intestinal-type mucus-containing) epithelial cells
(intestinal metaplasia). Each of the categories was expressed as
percent affected mucosa (the number of fields containing the lesion
divided by the total number of fields). Because mild antral
inflammation was present nonspecifically in all mouse groups, only
fundic and cardiac mucosae were scored. All sections collected were
examined in their entirety, and slides were read blind, i.e., without
knowledge of their source.
Statistics.
All experimental groups contained five to eight
mice. Group means were compared by nonparametric methods (Mann-Whitney
U test). A P value of <0.05 was considered statistically significant.
 |
RESULTS |
Adoptive transfer.
Flow cytometric analysis revealed that
isolated C57BL/6 splenocytes were 32% T cells (17% CD4 and 14% CD8)
and 59% B cells (CD45R/B220) (Table 1).
Flow cytometric analysis of cell markers in SCID mice was complicated
by low-level staining of large, undifferentiated cells. However, peak
populations revealed that cells from recipient SCID mice were enriched
with T cells (39%) and depleted of B cells (23%). The CD4-to-CD8
ratio of donor splenocytes (1:1.18) did not differ significantly from
that of recipient SCID mice (1:1.22, P > 0.5).
Nonrecipient SCID mice did not have a detectable peak in any of the
cell marker categories examined.
Gastritis in C57BL/6 and SCID mice.
Histologic evaluation of
gastritis included four categories of inflammation: PMN,
adenitis, gastritis, and mucus metaplasia (see definitions
above). These changes are illustrated in Fig. 1. Neutrophils were present in all groups
of C57BL/6 mice, infected and uninfected, although in infected mice
they increased late in the course of infection, their levels becoming
significantly elevated by 16 weeks after inoculation (Fig.
2A). Thus, neutrophils alone correlated
only weakly with infection status. In contrast, the levels of
inflammation of the other three categories increased markedly in
response to bacterial infection. Adenitis, gastritis, and metaplasia
were not present in uninfected mice, but their levels
significantly increased in infected mice by 6 or 8 weeks after
infection. By 16 weeks, all levels were 10- to 20-fold greater than
levels in uninfected C57BL/6 mice (Fig. 2A).

View larger version (134K):
[in this window]
[in a new window]
|
FIG. 1.
Histologic appearance of gastritis in an infected
C57BL/6 mouse killed 16 weeks after bacterial inoculation. (A) Junction
of normal and abnormal fundic mucosae. The affected area (to the right
of the arrow) is characterized by widespread mixed inflammation and the
loss of parietal and chief cells, which were replaced by
undifferentiated mucus cells (metaplasia). The area to the left of the
arrow is normal, characterized by gastric glands containing mostly
parietal and chief cells. Bar = 50 µm. (B) Higher magnification
demonstrating neutrophilic adenitis with the destruction of glands
(large arrow), mixed inflammation including lymphocytes and plasma
cells (arrowhead), and the almost complete replacement of gastric
glands by undifferentiated mucus cells. A single remaining parietal
cell is evident (small arrow). Bar = 14 µm.
|
|

View larger version (31K):
[in this window]
[in a new window]
|
FIG. 2.
Change in gastric inflammation and bacterial
colonization in infected C57BL/6 and congenic SCID mice between 5 and
16 weeks postinoculation (PI). (A) In C57BL/6 mice, all four indicators
of inflammation increased over the course of infection, but bacterial
colonization did not change. (B) Variable numbers of neutrophils were
present in infected and uninfected SCID mice at all experimental time
intervals. Otherwise, inflammation remained low and did not change over
the course of infection. Bacterial colonization was somewhat greater
than that in C57BL/6 mice and did not change over the course of
infection. *, P < 0.05 compared to result for
uninfected mice (week 0).
|
|
In contrast to infected mice, uninfected mice did not have adenitis,
gastritis, or metaplasia (Fig. 2A, week 0). Mild neutrophilic infiltrates were present in some individual uninfected mice (mean, 14%).
In infected SCID mice that did not receive splenocytes, inflammation
was minimal or nonexistent (Fig. 2B). Significant adenitis, gastritis,
and metaplasia did not occur in infected SCID mice killed 5, 6, 8, 12, or 16 weeks after inoculation, regardless of infection status. Mild
neutrophilic infiltrates were present in some infected and uninfected
SCID mice, involving up to 30% of the gastric mucosa in individual
mice, but there was no relationship between the presence of neutrophils
and infection with H. pylori.
Gastritis in recipient SCID mice.
In contrast to nonrecipient
SCID mice, H. pylori-infected SCID mice that received
splenocytes developed severe gastritis rapidly after adoptive transfer
(Fig. 3A and B). Within 2 weeks of the transfer of splenocytes (i.e., 6 weeks after infection) from either infected (Fig. 3A) or uninfected (Fig. 3B) C57BL/6 donors, SCID mice
developed widespread neutrophilic infiltrates (up to 100% of the
gastric mucosa), adenitis (up to 94%), gastritis (up to 90%), and
metaplasia (up to 50%). Mean inflammation of all four categories
continued to increase over time both in SCID mice receiving splenocytes
from infected donors and in those receiving splenocytes from uninfected
donors.

View larger version (43K):
[in this window]
[in a new window]
|
FIG. 3.
Changes in inflammation and colonization in infected and
uninfected SCID recipients of splenocytes from infected or uninfected
donors. (A) In infected recipients of splenocytes from infected donors,
levels of neutrophilic inflammation, adenitis, gastritis, and
metaplasia were significantly elevated 2 weeks posttransfer (PT) and
continued to increase over the course of the experiment. (B) Infected
recipients of cells from uninfected donors responded similarly, but
inflammation in all categories was somewhat more pronounced than in the
recipients of cells from infected donors. Bacterial colonization
decreased precipitously in both groups of mice. Uninfected recipients
of splenocytes from infected (C) or uninfected (D) donors developed
only minimal, inconsistent gastric inflammation. Slight increases in
levels of adenitis and gastritis in recipients of cells from infected
donors may have been due to cross-reaction with enteric flora. *,
P < 0.05 compared to results for nonrecipients (week
0). Note that since adoptive transfer was performed 4 weeks after
bacterial infection, the postinoculation interval (Fig. 2) was 4 weeks
longer than the PT interval. Thus, recipient SCID mice killed 12 weeks
PT had been colonized for as long as nonrecipient SCID mice killed 16 weeks postinoculation (see Materials and Methods).
|
|
In recipient SCID mice, the development of gastritis was dependent on
H. pylori infection as well as on adoptive transfer. In
contrast to infected recipient SCID mice, uninfected SCID mice developed only minimal gastritis whether or not they received splenocytes by adoptive transfer (Fig. 3C and D). Some uninfected SCID
mice which received cells from infected donors had neutrophilic infiltrates in up to 30% of the gastric mucosa or adenitis in up to
14% (Fig. 3C), but otherwise no histologic changes were detected.
Inflammation in all four categories was significantly more severe in
recipient SCID mice than in C57BL/6 mice (Fig. 2 and 3). In the most
severely affected group of C57BL/6 mice, those killed 16 weeks after
inoculation, inflammation was moderate. Adenitis and gastritis involved
less than 35% of the gastric mucosa, and metaplasia involved 6%. In
contrast, adenitis and gastritis involved from 50 to 75% of the
gastric mucosa in recipient SCID mice killed only 4 weeks after
transfer, and metaplasia involved about 30%. Inflammation continued to
increase in extent in recipient SCID mice and was somewhat more
widespread in recipients of cells from uninfected donors than in
recipients of cells from infected donors. Figure
4 compares four groups of infected mice:
SCID and C57BL/6 mice, SCID recipients of cells from infected donors,
and SCID recipients of cells from immune donors. Data were taken from Fig. 2 and 3. The contrast in the severity of gastritis between recipient SCID and C57BL/6 mice was readily apparent on casual inspection of histologic sections (Fig.
5).

View larger version (44K):
[in this window]
[in a new window]
|
FIG. 4.
Effects of host and donor strains on gastric
inflammation and bacterial colonization. SCID mice were killed 4 weeks
after transfer (8 weeks after infection), and C57BL/6 mice were killed
16 weeks after infection (the most severely affected C57BL/6 group).
Levels of neutrophilic inflammation, adenitis, gastritis, and
metaplasia were significantly higher in infected recipient SCID mice
than in infected C57BL/6 mice, even though C57BL/6 mice had been
infected 8 weeks longer. In SCID recipients of naive cells,
inflammation was the greatest and bacterial colonization was the least
of any of the groups. Infected nonrecipient SCID mice did not develop
inflammation, and bacterial colonization was highest in that group.
*, P < 0.05 compared to results for C57BL/6 mice.
|
|

View larger version (91K):
[in this window]
[in a new window]
|
FIG. 5.
(A) Severe inflammation in an infected recipient SCID
mouse infected with H. pylori, given splenocytes from an
uninfected donor, and killed 4 weeks after transfer (8 weeks after
bacterial inoculation). Note the marked, widespread infiltration of
inflammatory cells, loss of parietal cells, destruction of glands, and
overall thickening of the mucosa compared to panel B. (B) Moderate,
multifocal inflammation in an infected C57BL/6 mouse killed 8 weeks
after bacterial inoculation. Inflammation is less extensive and areas
of normal mucosa are retained (arrows). Bars = 60 µm.
|
|
Epithelial lesions.
In mice killed 3 months after transfer,
four morphologic indicators of epithelial damage were evaluated. Mucus
metaplasia was defined as described above. The percentages of gastric
mucosae with epithelial erosions and intestinal metaplasia were
evaluated in Genta-stained sections. Epithelial erosions were defined
as the loss of necrosis of surface epithelium accompanied by the flattening or proliferation of adjacent epithelial cells. Intestinal metaplasia was defined as the presence of intestinal-type (Alcian blue-positive) mucus in gastric epithelial cells. Finally, the labeling
index was determined in PCNA-stained sections. All four epithelial
changes correlated significantly with gastritis and adaptive immune
response (Table 2). Mucus metaplasia and
erosions were present only in mice with gastritis (infected C57BL/6) or severe gastritis (infected recipient SCID). The group with the most
severe gastritis (recipients of splenocytes from uninfected donors) had
the most extensive mucus metaplasia, intestinal metaplasia, and
epithelial erosions and the highest rate of epithelial proliferation (labeling index). In contrast, the highest degree of bacterial colonization was present in the group with no gastritis and no epithelial lesions (infected nonrecipient SCID mice). In addition to
significant differences in mouse groups, there was a statistically significant correlation between the severity of gastritis and epithelial changes. Slopes, significance levels (P), and
correlation coefficients (r2) of linear
correlations between gastritis and all four epithelial changes are
given in Table 3. Gastritis was
positively correlated with epithelial changes.
Bacterial colonization.
Concentrations of H. pylori
organisms colonizing C57BL/6 mice ranged from 2 × 107
to 3 × 107 CFU/g of gastric mucosa and did not change
significantly over the course of the experiment despite increasing
inflammation (Fig. 2A). In SCID mice, however, bacterial colonization
was inversely correlated with the severity of gastritis. In
nonrecipient SCID mice with no gastritis, concentrations ranged from
2 × 107 to 6 × 107 CFU/g and did
not change with time (Fig. 2B). In contrast, in recipient SCID mice,
colonization decreased as the severity of inflammation increased (Fig.
3A and B). In SCID mice that received cells from infected donors, the
concentration decreased more than 200-fold, from >5 × 107 CFU/g 1 week after transfer to 2 × 105 CFU/g 12 weeks after transfer; in those receiving cells
from uninfected donors, the concentration decreased more than 300-fold, from >3 × 107 CFU/g 1 week after transfer to fewer
than 9 × 104 CFU/g 8 weeks after transfer
(P = 0.055 compared to value for mice given cells from
infected donors). Three of five recipient mice given cells from
uninfected donors were culture negative 8 weeks after transfer.
Levels of bacterial colonization were reflected in the number of
bacteria in Genta-stained sections. Nonrecipient SCID mice often had
large numbers of bacteria packed in glands in all areas of the gastric
mucosa. In contrast, bacteria were difficult to find in sections from
other groups of infected mice and were not apparent in mice with the
most severe gastritis (recipient SCID mice). Strikingly, the large
numbers of bacteria in nonrecipient SCID mice were closely associated
with the gastric mucosa, but no epithelial lesions were present in
these mice. As described above (Table 2), epithelial lesions were found
only in mice with few bacteria and severe inflammation. Overall, there
was a negative correlation between colonization and both gastritis and
epithelial lesions (Table 3).
DTH response.
A DTH response, as measured by a marked,
statistically significant increase in footpad thickness 24 h after
antigen injection, was present only in infected recipient SCID mice.
DTH response was absent in both infected C57BL/6 (Fig.
6A) and infected nonrecipient SCID (Fig.
6B) mice. For infected recipient SCID mice, however, mean footpad
swelling increased markedly both in groups receiving cells from
infected donors (Fig. 7A) and in those
receiving cells from uninfected donors (not shown). Slight increases in
mean footpad thickness were present in uninfected SCID mice which
received cells from infected donors and were killed 2, 4, and 8 weeks
after transfer, but these differences were small, were not
statistically significant, and did not persist to 12 weeks (Fig. 7B).

View larger version (15K):
[in this window]
[in a new window]
|
FIG. 6.
Change in DTH response (footpad swelling) and serum
immune response to H. pylori antigens in infected C57BL/6
and SCID mice. (A) C57BL/6 mice did not develop a DTH response to
H. pylori antigens even 16 weeks postinoculation (PI) but
did develop a strong serum IgG response by 5 weeks PI (DTH was not
measured 12 weeks PI). *, P < 0.05 compared to
results for uninfected mice. (B) Infected SCID mice developed neither
DTH nor serum immune responses (serum IgG was undetectable).
OD405, optical density at 405 nm.
|
|

View larger version (15K):
[in this window]
[in a new window]
|
FIG. 7.
Change in DTH response (footpad swelling) and serum
immune response to H. pylori antigens in infected and
uninfected recipient SCID mice. (A) Infected SCID recipients of
splenocytes from infected donors developed strong DTH responses by 2 weeks posttransfer (PT). Serum IgG responses developed later and
remained consistently lower than those in C57BL/6 mice. Responses of
SCID recipients of splenocytes from uninfected donors were similar (not
shown). *, P < 0.05 compared to results for
nonrecipients. (B) DTH and serum immune responses were low and
inconsistent in uninfected SCID recipients of splenocytes from infected
donors. OD405, optical density at 405 nm.
|
|
Immunoglobulin response.
Infected C57BL/6 mice responded to
H. pylori infection with strong systemic anti-H.
pylori IgG responses that were detectable within 5 weeks of
inoculation and reached maximal levels (indicated by optical density,
as determined by ELISA) by 6 weeks (Fig. 6A). In contrast, infected
SCID mice did not produce any anti-H. pylori IgG (Fig. 6B),
and IgG levels in uninfected C57BL/6 mice remained low. Infected
recipient SCID mice developed variable levels of anti-H.
pylori IgG which gradually increased after transfer but did not
reach the levels found in C57BL/6 mice (Fig. 7).
 |
DISCUSSION |
This study revealed several novel and important findings. First,
we have shown that gastritis and epithelial lesions due to H. pylori are dependent on an intact adaptive immune response and do
not develop in T- and B-cell-deficient SCID mice. These results differ
from those of a previous study, in which the responses of SCID and
wild-type mice to Helicobacter felis did not differ (4). There were a number of differences between that study and the present one which likely explain the different outcomes. Most
likely to have contributed to the differences in these studies is the
difference in the mouse strains used. Blanchard et al. (4)
used C.B-17 mice and congenic SCID mice. These mice are essentially
BALB/c mice with a single genetic difference (an IgG isotype)
(5). BALB/c mice have been shown in several studies to
develop only minimal gastritis in response to both H. felis (32, 38) and H. pylori (38). Based on
reported results of these studies as well as our own observations (not
shown), BALB/c mice would be expected to have minimal gastritis at 8 weeks after infection (the sacrifice time used in the Blanchard study).
Thus, the lack of difference in inflammation and colonization in the Blanchard study may be largely attributable to the failure of the
wild-type mice to respond rather than to any significant response by
the SCID mice.
A second difference between C.B-17 and C57BL/6 SCID mice is the
demonstrated "leakiness" of the former strain. C.B-17 SCID mice are
known to produce antibody in increasing concentrations as they age
(5, 39), and the possibility that some adaptive immune
function remains in these mice must be considered when using this
strain. Thus, it is conceivable that the SCID mice in the Blanchard
study did develop some specific immune response to H. pylori, resulting in inflammation that approached the gastritis (albeit mild) described for the wild-type mice. In contrast, C57BL/6 mice are not known to be leaky. Furthermore, in the present study, all
SCID mice were tested for circulating mouse IgG and shown to be
negative at the onset of the study. Mice which did not receive splenocytes remained IgG negative, did not develop H. pylori-specific antibody in response to infection, and did not
develop DTH responses, suggesting that they remained immunodeficient
throughout the study.
The second important finding of this study is the severity of gastritis
in recipient SCID mice. The lesions are notable for two reasons. The
most intriguing aspect is the difference between recipient SCID and
donor C57BL/6 mice. The marked increases in the severity and rapidity
of the onset of gastritis in recipient SCID mice (within 2 weeks of
transfer), as well as the induction of DTH not seen in donor mice,
indicate a loss of regulation resulting in the derepression of
inflammation in recipient SCID mice. It is likely that regulatory
cells, cytokines, or both suppress inflammation in normal mice,
dampening and delaying gastritis. The absence of these regulatory
influences in SCID mice results in the lesions that were produced in
this study. While the effector cells are likely T cells (as evidenced
by the correlation with DTH and the T-cell enrichment of the engrafted
cells), the identification of the regulatory population in donor mice
was not addressed by this study.
In addition to providing evidence suggesting the regulation of
inflammation due to H. pylori in normal mice, the severe
gastritis in recipient SCID mice represents an important addition to
the growing number of animal models of disease due to H. pylori. The overall severity and rapidity of the onset of the
lesions described here are more extensive and acute than those
described for other animals colonized with H. pylori.
Lesions of comparable severity and rapid onset (within 4 weeks) have
been described for interleukin-10-deficient mice colonized with
H. felis (2), and several studies have described
severe lesions after prolonged (several months to years) colonization
by H. felis (24, 25, 38) or H. pylori
(27). However, in most studies, colonization by H. pylori resulted in relatively mild gastritis unaccompanied by
epithelial lesions (9, 10, 18, 23).
The third important finding of this study is that epithelial lesions
depend on the presence of gastritis and that by themselves, even large
numbers of bacteria in close contact with the gastric epithelium do not
cause epithelial erosions, metaplasia, or increased epithelial
proliferation in vivo in the absence of a host response. These results
indicate that if bacterial virulence factors are important in
determining the outcome of infection, it is likely that their roles are
in the induction of host response rather than in having a direct
deleterious effect on host epithelial cells.
In addition to the three important findings described above, several
other characteristics of H. pylori gastritis are addressed in this study. This study is the first to describe the effect of
adoptive transfer in H. pylori-infected immunodeficient
mice. A previous investigation by Mohammadi et al. examined the effect of adoptive transfer between groups of H. felis-infected
C57BL/6 mice (31). In that study, findings were similar to
those of the present study in that adoptive transfer exacerbated
gastritis and suppressed colonization, but the differences in the
severity of gastritis between nonrecipient and recipient mice were not as marked as they were in the present study. One interesting difference between the results of Mohammadi et al. and our own was the effect of
prior exposure to antigen in donor mice. Mohammadi et al. found that
splenocytes from naturally infected or immunized donors induced more
severe gastritis than did splenocytes from uninfected donors. In our
study, splenocytes from uninfected donors induced more severe gastritis
and suppressed bacterial colonization more than splenocytes from
infected donors did.
Differences between the study by Mohammadi et al. and the present study
are likely due to differences in mouse strain, bacterial strain, and
experimental protocol. Probably the most significant difference was
that adoptive transfer in that study was done between groups of C57BL/6
mice rather than between C57BL/6 and SCID mice, as was done in the
present study. Thus, the recipient mice were immunocompetent, and the
contribution of the immune response of the recipients to the outcome
could not be determined. Because the recipients in the present study
were immunodeficient, endogenous adaptive immunity did not contribute
to their responses. Other differences included the number of
splenocytes transferred; the bacterial strain (H. felis was
used in the study by Mohammadi et al.); and the infection, transfer,
and sacrifice times. Finally, Mohammadi et al. did not evaluate DTH
responses in their mice.
Other findings of this study are of interest. The strong inverse
correlation between gastritis and bacterial colonization is evidence
that the host immune response is effective in the suppression of
bacterial colonization. This is compatible with other studies showing
that increased immunity (e.g., due to vaccination) is accompanied by
increased gastritis (postimmunization gastritis) as well as suppressed
bacterial colonization (15). The correlation of DTH with
severe gastritis is also compatible with previous studies suggesting
that T-cell-mediated immunity is necessary for bacterial clearance
(and, by extension, for the induction of gastritis) (3, 14, 31,
35). Finally, the development of DTH in infected recipient SCID
mice but not infected donors is further evidence of immune regulation
in donor mice.
The overall results of this study confirm that host immunity is
necessary for both gastritis and the suppression of H. pylori colonization in infected mice. In addition, we demonstrate
that epithelial damage is dependent on the host immune response rather than resulting from a direct bacterial effect, and we provide evidence
that T-cell-dependent immunity is necessary for both gastritis and
bacterial suppression. Finally, we demonstrate that gastritis is
derepressed in SCID recipients, suggesting that gastritis is regulated
and thus suppressed in normal infected C57BL/6 mice.
 |
ACKNOWLEDGMENTS |
This work was supported in part by PHS grants R01 AI43643,
CA67498-01, and R29 DK-45340 from the NIH.
We thank Toni Hoepf for excellent technical assistance, Jon Rosenberg
for animal care, and Charley Orosz for help in planning and evaluating experiments.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Veterinary Biosciences, Ohio State University, 1925 Coffey Rd.,
Columbus, OH 43210. Phone: (614) 292-9667. Fax: (614) 292-6473. E-mail: eaton.1{at}osu.edu.
Editor:
R. N. Moore
 |
REFERENCES |
| 1.
|
Atherton, J. C.,
P. Cao,
R. M. Peek,
M. K. R. Tummuru,
M. J. Blaser, and T. L. Cover.
1995.
Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori association of specific vacA types with cytotoxin production and peptic ulceration.
J. Biol. Chem.
270:17771-17777[Abstract/Free Full Text].
|
| 2.
|
Berg, D. J.,
N. A. Lynch,
R. G. Lynch, and D. M. Lauricella.
1998.
Rapid development of severe hyperplastic gastritis with gastric epithelial dedifferentiation in Helicobacter felis-infected IL-10( / ) mice.
Am. J. Pathol.
152:1377-1386[Abstract].
|
| 3.
|
Blanchard, T.,
S. Czinn,
R. Redline,
N. Sigmund,
G. Harriman, and J. Nedrud.
1999.
Antibody-independent protective mucosal immunity to gastric helicobacter infection in mice.
Cell. Immunol.
191:74-80[Medline].
|
| 4.
|
Blanchard, T. G.,
S. J. Czinn,
J. G. Nedrud, and R. W. Redline.
1995.
Helicobacter-associated gastritis in SCID mice.
Infect. Immun.
63:1113-1115[Abstract].
|
| 5.
|
Bosma, G. C.,
R. P. Custer, and M. J. Bosma.
1983.
A severe combined immunodeficiency mutation in the mouse.
Nature
301:527-530[Medline].
|
| 6.
|
Cover, T. L., and M. J. Blaser.
1992.
Purification and characterization of the vacuolating toxin from Helicobacter pylori.
J. Biol. Chem.
267:10570-10575[Abstract/Free Full Text].
|
| 7.
|
Crabtree, J. E.,
Z. Xiang,
I. J. D. Lindley,
D. S. Tompkins,
R. Rappuoli, and A. Covacci.
1995.
Induction of interleukin-8 secretion from gastric epithelial cells by a CagA negative isogenic mutant of Helicobacter pylori.
J. Clin. Pathol.
48:967-969[Abstract/Free Full Text].
|
| 8.
|
Eaton, K. A.,
T. L. Cover,
M. K. R. Tummuru,
M. J. Blaser, and S. Krakowka.
1997.
Role of vacuolating cytotoxin in gastritis due to Helicobacter pylori in gnotobiotic piglets.
Infect. Immun.
65:3462-3464[Abstract].
|
| 9.
|
Eaton, K. A.,
F. E. Dewhirst,
B. J. Paster,
N. Tzellas,
B. E. Coleman,
J. Paola, and R. Sherding.
1996.
Prevalence and varieties of Helicobacter species in dogs from random sources and pet dogs: animal and public health implications.
J. Clin. Microbiol.
34:3165-3170[Abstract].
|
| 10.
|
Eaton, K. A.,
D. R. Morgan, and S. Krakowka.
1989.
Campylobacter pylori virulence factors in gnotobiotic piglets.
Infect. Immun.
57:1119-1125[Abstract/Free Full Text].
|
| 11.
|
Eaton, K. A.,
D. R. Morgan, and S. Krakowka.
1992.
Motility as a factor in the colonisation of gnotobiotic piglets by Helicobacter pylori.
J. Med. Microbiol.
37:123-127[Abstract].
|
| 12.
|
Eaton, K. A.,
M. J. Radin, and S. Krakowka.
1995.
An animal model of gastric ulcer due to bacterial gastritis in mice.
Vet. Pathol.
32:489-497[Abstract].
|
| 13.
|
Eaton, K. A.,
M. J. Radin,
L. Kramer,
R. Wack,
R. Sherding,
S. Krakowka,
J. G. Fox, and D. R. Morgan.
1993.
Epizootic gastritis associated with gastric spiral bacilli in cheetahs (Acinonyx jubatus).
Vet. Pathol.
30:55-63[Abstract].
|
| 14.
|
Ermak, T.,
P. Giannasca,
R. Nichols,
G. Myers,
J. Nedrud,
R. Weltzin,
C. Lee,
H. Kleanthous, and T. Monath.
1998.
Immunization of mice with urease vaccine affords protection against Helicobacter pylori infection in the absence of antibodies and is mediated by MHC class II-restricted responses.
J. Exp. Med.
188:2277-2288[Abstract/Free Full Text].
|
| 15.
|
Ermak, T. H.,
R. Ding,
B. Ekstein,
J. Hill,
G. A. Myers,
C. K. Lee,
J. Pappo,
H. K. Kleanthous, and T. P. Monath.
1997.
Gastritis in urease-immunized mice after Helicobacter felis challenge may be due to residual bacteria.
Gastroenterology
113:1118-1128[Medline].
|
| 16.
|
Ferrero, R. L.,
J. M. Thiberge,
I. Kansau,
N. Wuscher,
M. Huerre, and A. Labigne.
1995.
The GroES homolog of Helicobacter pylori confers protective immunity against mucosal infection in mice.
Proc. Natl. Acad. Sci. USA
92:6499-6503[Abstract/Free Full Text].
|
| 17.
|
Ferrero, R. L.,
J. M. Thiberge, and A. Labigne.
1997.
Local immunoglobulin G antibodies in the stomach may contribute to immunity against Helicobacter infection in mice.
Gastroenterology
113:185-194[Medline].
|
| 18.
|
Fox, J. G.,
M. Batchelder,
R. Marini,
L. Yan,
L. Handt,
X. Li,
B. Shames,
A. Hayward,
J. Campbell, and J. C. Murphy.
1995.
Helicobacter pylori-induced gastritis in the domestic cat.
Infect. Immun.
63:2674-2681[Abstract].
|
| 19.
|
Fox, J. G.,
X. T. Li,
R. J. Cahill,
K. Andrutis,
A. K. Rustgi,
R. Odze, and T. C. Wang.
1996.
Hypertrophic gastropathy in Helicobacter felis-infected wild-type C57BL/6 mice and p53 hemizygous transgenic mice.
Gastroenterology
110:155-166[Medline].
|
| 20.
|
Genta, R. M.,
G. O. Robason, and D. Y. Graham.
1994.
Simultaneous visualization of Helicobacter pylori and gastric morphology: a new stain.
Hum. Pathol.
25:221-226[Medline].
|
| 21.
|
Hermanns, W.,
K. Kregel,
W. Breuer, and J. Lechner.
1995.
Helicobacter-like organisms: histopathological examination of gastric biopsies from dogs and cats.
J. Comp. Pathol.
112:307-318[Medline].
|
| 22.
|
Kirchgessner, C. U.,
C. K. Patil,
J. W. Evans,
C. A. Cuomo,
L. M. Fried,
T. Carter,
M. A. Oettinger, and J. M. Brown.
1995.
DNA-dependent kinase (p350) as a candidate gene for the murine SCID defect.
Science
267:1178-1183[Abstract/Free Full Text].
|
| 23.
|
Krakowka, S.,
D. R. Morgan,
W. G. Kraft, and R. D. Leunk.
1987.
Establishment of gastric Campylobacter pylori infection in the neonatal gnotobiotic piglet.
Infect. Immun.
55:2789-2796[Abstract/Free Full Text].
|
| 24.
|
Lee, A.,
J. G. Fox,
G. Otto, and J. Murphy.
1990.
A small animal model of human Helicobacter pylori active chronic gastritis.
Gastroenterology
99:1315-1323[Medline].
|
| 25.
|
Lee, A.,
J. O'Rourke,
M. C. De Ungria,
B. Robertson,
G. Daskalopoulos, and M. F. Dixon.
1997.
A standardized mouse model of Helicobacter pylori infection: introducing the Sydney strain.
Gastroenterology
112:1386-1397[Medline].
|
| 26.
|
Marshall, B. J., and J. R. Warren.
1984.
Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration.
Lancet
i:1311-1315.
|
| 27.
|
Matsumoto, S.,
Y. Washizuka,
Y. Matsumoto,
S. Tawara,
F. Ikeda,
Y. Yokota, and M. Karita.
1997.
Induction of ulceration and severe gastritis in Mongolian gerbil by Helicobacter pylori infection.
J. Med. Microbiol.
46:391-397[Abstract].
|
| 28.
|
Michetti, P.,
I. Corthesy-Theulaz,
C. Davin,
R. Haas,
A. C. Vaney,
M. Heitz,
J. Bille,
J. P. Kraehenbuhl,
E. Saraga, and A. L. Blum.
1994.
Immunization of BALB/c mice against Helicobacter felis infection with Helicobacter pylori urease.
Gastroenterology
107:1002-1011[Medline].
|
| 29.
|
Mitchell, H. M.,
A. Lee,
J. Berkowicz, and T. Borody.
1988.
The use of serology to diagnose active Campylobacter pylori infection.
Med. J. Aust.
149:604-609[Medline].
|
| 30.
|
Mohammadi, M.,
S. Czinn,
R. Redline, and J. Nedrud.
1996.
Helicobacter-specific cell-mediated immune responses display a predominant Th1 phenotype and promote a delayed-type hypersensitivity response in the stomachs of mice.
J. Immunol.
156:4729-4738[Abstract].
|
| 31.
|
Mohammadi, M.,
J. Nedrud,
R. Redline,
N. Lycke, and S. J. Czinn.
1997.
Murine CD4 T-cell response to Helicobacter infection: TH1 cells enhance gastritis and TH2 cells reduce bacterial load.
Gastroenterology
113:1848-1857[Medline].
|
| 32.
|
Mohammadi, M.,
R. Redline,
J. Nedrud, and S. Czinn.
1996.
Role of the host in pathogenesis of Helicobacter-associated gastritis: H. felis infection of inbred and congenic mouse strains.
Infect. Immun.
64:238-245[Abstract].
|
| 33.
|
Neiger, R.,
C. Dieterich,
A. Burnens,
A. Waldvogel,
I. Corthésy-Theulaz,
F. Halter,
B. Lauterburg, and A. Schmassmann.
1998.
Detection and prevalence of Helicobacter infection in pet cats.
J. Clin. Microbiol.
36:634-637[Abstract/Free Full Text].
|
| 34.
|
Norris, C. R.,
S. L. Marks,
K. A. Eaton,
S. Z. Torabian,
R. J. Munn, and J. V. Solnick.
1999.
Healthy cats are commonly colonized with "Helicobacter heilmannii" that is associated with minimal gastritis.
J. Clin. Microbiol.
37:189-194[Abstract/Free Full Text].
|
| 35.
|
Pappo, J.,
D. Torrey,
L. Castriotta,
A. Savinainen,
Z. Kabok, and A. Ibraghimov.
1999.
Helicobacter pylori infection in immunized mice lacking major histocompatibility complex class I and class II functions.
Infect. Immun.
67:337-341[Abstract/Free Full Text].
|
| 36.
|
Peek, R. M., Jr.,
S. A. Thompson,
J. P. Donahue,
K. T. Tham,
J. C. Atherton,
M. J. Blaser, and G. G. Miller.
1998.
Adherence to gastric epithelial cells induces expression of a Helicobacter pylori gene, iceA, that is associated with clinical outcome.
Proc. Assoc. Am. Physicians
110:531-544[Medline].
|
| 37.
|
Peek, R. M., Jr.,
G. G. Miller,
K. T. Tham,
G. I. Perez-Perez,
X. Zhao,
J. C. Atherton, and M. J. Blaser.
1995.
Heightened inflammatory response and cytokine expression in vivo to cagA(+) Helicobacter pylori strains.
Lab. Investig.
73:760-770[Medline].
|
| 38.
|
Sakagami, T.,
M. Dixon,
J. O'Rourke,
R. Howlett,
F. Alderuccio,
J. Vella,
T. Shimoyama, and A. Lee.
1996.
Atrophic gastric changes in both Helicobacter felis and Helicobacter pylori infected mice are host dependent and separate from antral gastritis.
Gut
39:639-648[Abstract/Free Full Text].
|
| 39.
|
Seydel, K. B., and S. L. Stanley, Jr.
1996.
SCID mice and the study of parasitic disease.
Clin. Microbiol. Rev.
9:126-134[Medline].
|
| 40.
|
Telford, J. L.,
P. Ghiara,
M. Dell'Orco,
M. Comanducci,
D. Burroni,
M. Bugnoli,
M. F. Tecce,
S. Censini,
A. Covacci, and Z. Xiang.
1994.
Gene structure of the Helicobacter pylori cytotoxin and evidence of its key role in gastric disease.
J. Exp. Med.
179:1653-1658[Abstract/Free Full Text].
|
| 41.
|
Yamasaki, K.,
H. Suematsu, and T. Takahashi.
1998.
Comparison of gastric lesions in dogs and cats with and without gastric spiral organisms.
J. Am. Vet. Med. Assoc.
212:529-533[Medline].
|
Infection and Immunity, September 1999, p. 4594-4602, Vol. 67, No. 9
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Nagai, S., Mimuro, H., Yamada, T., Baba, Y., Moro, K., Nochi, T., Kiyono, H., Suzuki, T., Sasakawa, C., Koyasu, S.
(2007). Role of Peyer's patches in the induction of Helicobacter pylori-induced gastritis. Proc. Natl. Acad. Sci. USA
104: 8971-8976
[Abstract]
[Full Text]
-
Caruso, R., Fina, D., Peluso, I., Fantini, M. C., Tosti, C., Blanco, G. D. V., Paoluzi, O. A., Caprioli, F., Andrei, F., Stolfi, C., Romano, M., Ricci, V., MacDonald, T. T., Pallone, F., Monteleone, G.
(2007). IL-21 Is Highly Produced in Helicobacter pylori-Infected Gastric Mucosa and Promotes Gelatinases Synthesis. J. Immunol.
178: 5957-5965
[Abstract]
[Full Text]
-
Algood, H. M. S., Cover, T. L.
(2006). Helicobacter pylori Persistence: an Overview of Interactions between H. pylori and Host Immune Defenses. Clin. Microbiol. Rev.
19: 597-613
[Abstract]
[Full Text]
-
Eaton, K. A., Benson, L. H., Haeger, J., Gray, B. M.
(2006). Role of Transcription Factor T-bet Expression by CD4+ Cells in Gastritis Due to Helicobacter pylori in Mice.. Infect. Immun.
74: 4673-4684
[Abstract]
[Full Text]
-
Anderson, K. M., Czinn, S. J., Redline, R. W., Blanchard, T. G.
(2006). Induction of CTLA-4-Mediated Anergy Contributes to Persistent Colonization in the Murine Model of Gastric Helicobacter pylori Infection. J. Immunol.
176: 5306-5313
[Abstract]
[Full Text]
-
Lopez-Diaz, L., Hinkle, K. L., Jain, R. N., Zavros, Y., Brunkan, C. S., Keeley, T., Eaton, K. A., Merchant, J. L., Chew, C. S., Samuelson, L. C.
(2006). Parietal cell hyperstimulation and autoimmune gastritis in cholera toxin transgenic mice. Am. J. Physiol. Gastrointest. Liver Physiol.
290: G970-G979
[Abstract]
[Full Text]
-
Dohi, T., Fujihashi, K., Koga, T., Etani, Y., Yoshino, N., Kawamura, Y. I., McGhee, J. R.
(2004). CD4+CD45RBHi Interleukin-4 Defective T Cells Elicit Antral Gastritis and Duodenitis. Am. J. Pathol.
165: 1257-1268
[Abstract]
[Full Text]
-
Sebkova, L., Pellicano, A., Monteleone, G., Grazioli, B., Guarnieri, G., Imeneo, M., Pallone, F., Luzza, F.
(2004). Extracellular Signal-Regulated Protein Kinase Mediates Interleukin 17 (IL-17)-Induced IL-8 Secretion in Helicobacter pylori-Infected Human Gastric Epithelial Cells. Infect. Immun.
72: 5019-5026
[Abstract]
[Full Text]
-
Nyan, D. C., Welch, A. R., Dubois, A., Coleman, W. G. Jr.
(2004). Development of a Noninvasive Method for Detecting and Monitoring the Time Course of Helicobacter pylori Infection. Infect. Immun.
72: 5358-5364
[Abstract]
[Full Text]
-
Eaton, K. A., Logan, S. M., Baker, P. E., Peterson, R. A., Monteiro, M. A., Altman, E.
(2004). Helicobacter pylori with a Truncated Lipopolysaccharide O Chain Fails To Induce Gastritis in SCID Mice Injected with Splenocytes from Wild-Type C57BL/6J Mice. Infect. Immun.
72: 3925-3931
[Abstract]
[Full Text]
-
Altman, E., Smirnova, N., Li, J., Aubry, A., Logan, S. M.
(2003). Occurrence of a nontypable Helicobacter pylori strain lacking Lewis blood group O antigens and DD-heptoglycan: evidence for the role of the core {alpha}1,6-glucan chain in colonization. Glycobiology
13: 777-783
[Abstract]
[Full Text]
-
Yamaguchi, H., Osaki, T., Taguchi, H., Sato, N., Toyoda, A., Takahashi, M., Kai, M., Nakata, N., Komatsu, A., Atomi, Y., Kamiya, S.
(2003). Effect of Bacterial Flora on Postimmunization Gastritis following Oral Vaccination of Mice with Helicobacter pylori Heat Shock Protein 60. CVI
10: 808-812
[Abstract]
[Full Text]
-
Wanken, A. E., Conway, T., Eaton, K. A.
(2003). The Entner-Doudoroff Pathway Has Little Effect on Helicobacter pylori Colonization of Mice. Infect. Immun.
71: 2920-2923
[Abstract]
[Full Text]
-
Raghavan, S., Svennerholm, A.-M., Holmgren, J.
(2002). Effects of Oral Vaccination and Immunomodulation by Cholera Toxin on Experimental Helicobacter pylori Infection, Reinfection, and Gastritis. Infect. Immun.
70: 4621-4627
[Abstract]
[Full Text]
-
Garhart, C. A., Redline, R. W., Nedrud, J. G., Czinn, S. J.
(2002). Clearance of Helicobacter pylori Infection and Resolution of Postimmunization Gastritis in a Kinetic Study of Prophylactically Immunized Mice. Infect. Immun.
70: 3529-3538
[Abstract]
[Full Text]
-
Obonyo, M., Guiney, D. G., Harwood, J., Fierer, J., Cole, S. P.
(2002). Role of Gamma Interferon in Helicobacter pylori Induction of Inflammatory Mediators during Murine Infection. Infect. Immun.
70: 3295-3299
[Abstract]
[Full Text]
-
Zavros, Y., Rieder, G., Ferguson, A., Merchant, J. L.
(2002). Gastritis and Hypergastrinemia Due to Acinetobacter lwoffii in Mice. Infect. Immun.
70: 2630-2639
[Abstract]
[Full Text]
-
Eaton, K. A., Gilbert, J. V., Joyce, E. A., Wanken, A. E., Thevenot, T., Baker, P., Plaut, A., Wright, A.
(2002). In Vivo Complementation of ureB Restores the Ability of Helicobacter pylori To Colonize. Infect. Immun.
70: 771-778
[Abstract]
[Full Text]
-
Eaton, K. A., Mefford, M., Thevenot, T.
(2001). The Role of T Cell Subsets and Cytokines in the Pathogenesis of Helicobacter pylori Gastritis in Mice. J. Immunol.
166: 7456-7461
[Abstract]
[Full Text]
-
Eaton, K. A., Kersulyte, D., Mefford, M., Danon, S. J., Krakowka, S., Berg, D. E.
(2001). Role of Helicobacter pylori cag Region Genes in Colonization and Gastritis in Two Animal Models. Infect. Immun.
69: 2902-2908
[Abstract]
[Full Text]
-
Peterson, R. A., Danon, S. J., Eaton, K. A.
(2001). Comparison of Gastritis and Gastric Epithelial Proliferation in Helicobacter heilmannii-infected Nude and BALB/c Mice. Vet Pathol
38: 173-183
[Abstract]
[Full Text]
-
Eaton, K. A., Mefford, M. E.
(2001). Cure of Helicobacter pylori Infection and Resolution of Gastritis by Adoptive Transfer of Splenocytes in Mice. Infect. Immun.
69: 1025-1031
[Abstract]
[Full Text]
-
Solnick, J. V., Schauer, D. B.
(2001). Emergence of Diverse Helicobacter Species in the Pathogenesis of Gastric and Enterohepatic Diseases. Clin. Microbiol. Rev.
14: 59-97
[Abstract]
[Full Text]
-
MACDONALD, T T
(2001). The worm turns on Helicobacter pylori. Gut
48: 10-11
[Full Text]
-
Smythies, L. E., Waites, K. B., Lindsey, J. R., Harris, P. R., Ghiara, P., Smith, P. D.
(2000). Helicobacter pylori-Induced Mucosal Inflammation Is Th1 Mediated and Exacerbated in IL-4, But Not IFN-{gamma}, Gene-Deficient Mice. J. Immunol.
165: 1022-1029
[Abstract]
[Full Text]
-
Young, V. B., Dangler, C. A., Fox, J. G., Schauer, D. B.
(2000). Chronic Atrophic Gastritis in SCID Mice Experimentally Infected with Campylobacter fetus. Infect. Immun.
68: 2110-2118
[Abstract]
[Full Text]
-
Zavros, Y., Rieder, G., Ferguson, A., Samuelson, L. C., Merchant, J. L.
(2002). Hypergastrinemia in response to gastric inflammation suppresses somatostatin. Am. J. Physiol. Gastrointest. Liver Physiol.
282: G175-G183
[Abstract]
[Full Text]